Melanoma and Skin Cancer Awareness Month: Research highlights

May is Skin Cancer Awareness Month. With this collection of research in the field, the Nature Communications cancer team aim to increase knowledge of the disease and provide updates in melanoma/skin cancer prevention and detection.

Published in Cancer

Melanoma and Skin Cancer Awareness Month: Research highlights
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Skin cancer is the most common malignant disease in Caucasians. 

The disease includes a diverse group of benign and malignant growth from different cell types, both cutaneous and extracutaneous, and that have different clinical outcomes. The most common types are basal cell carcinoma, squamous cell carcinoma and melanoma. The majority of skin cancer deaths result from melanoma. The most important etiological factors include UV light, ionizing radiation, and certain chemical carcinogens. Surgical removal is the primary means of treatment for most skin cancers. Other current treatments include chemotherapy, immunotherapy and targeted therapies.

Browse the collection to learn more >>

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Cancer Biology
Life Sciences > Biological Sciences > Cancer Biology

Related Collections

With Collections, you can get published faster and increase your visibility.

Women's Health

A selection of recent articles that highlight issues relevant to the treatment of neurological and psychiatric disorders in women.

Publishing Model: Hybrid

Deadline: Ongoing

Advances in neurodegenerative diseases

This Collection aims to bring together research from various domains related to neurodegenerative conditions, encompassing novel insights into disease pathophysiology, diagnostics, therapeutic developments, and care strategies. We welcome the submission of all papers relevant to advances in neurodegenerative disease.

Publishing Model: Hybrid

Deadline: Dec 24, 2025